Syncom Formulations (India) Limited (NSE:SYNCOMF)
India · Delayed Price · Currency is INR 19.98
-0.03 (-0.15%)
Sep 24, 2026, 2:45 PM IST
NSE:SYNCOMF Market Cap
NSE:SYNCOMF has a market cap or net worth of 18.83 billion as of September 23, 2026. Its market cap has increased by 15.31% in one year.
Market Cap
18.83B
Enterprise Value
17.71B
Revenue
4.98B
Ranking
n/a
PE Ratio
22.01
Stock Price
19.98
ChartMarket Cap Chart
Since December 31, 2001, NSE:SYNCOMF's market cap has increased from 267.05M to 18.83B, an increase of 6,950.48%. That is a compound annual growth rate of 18.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 18.83B | 40.36% |
| Dec 31, 2025 | 13.41B | -28.65% |
| Dec 31, 2024 | 18.80B | 32.98% |
| Dec 29, 2023 | 14.14B | 69.37% |
| Dec 30, 2022 | 8.35B | -23.58% |
| Dec 31, 2021 | 10.92B | 305.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 35.22B |
| Solara Active Pharma Sciences | 34.88B |
| Sakar Healthcare | 25.87B |
| Indoco Remedies | 23.18B |
| Windlas Biotech | 22.23B |
| Beta Drugs | 22.18B |
| Anlon Healthcare | 15.78B |
| Jagsonpal Pharmaceuticals | 14.88B |